88 related articles for article (PubMed ID: 15666861)
21. Evaluation of factors influencing replication of serotype 1 Marek's disease vaccines in the chicken lung.
Gimeno IM; Cortes AL
Avian Pathol; 2010 Apr; 39(2):71-9. PubMed ID: 20390540
[TBL] [Abstract][Full Text] [Related]
22. Transformation of primary chick embryo fibroblasts by Marek's disease virus.
Buranathai C; Rodriguez J; Grose C
Virology; 1997 Dec; 239(1):20-35. PubMed ID: 9426443
[TBL] [Abstract][Full Text] [Related]
23. Partial inhibition by turkey herpesvirus of serotype 2 Marek's disease virus plaque formation and in vivo infectivity.
Witter RL; Bacon LD; Calvert JG
Avian Dis; 1994; 38(4):800-9. PubMed ID: 7702514
[TBL] [Abstract][Full Text] [Related]
24. Insertion of reticuloendotheliosis virus long terminal repeat into a bacterial artificial chromosome clone of a very virulent Marek's disease virus alters its pathogenicity.
Mays JK; Silva RF; Kim T; Fadly A
Avian Pathol; 2012; 41(3):259-65. PubMed ID: 22702453
[TBL] [Abstract][Full Text] [Related]
25. Marek's disease virus (Kekava strain) replication in chickens, chick embryos and cell cultures.
Yakovleva LS; Mazurenko NP; Gunenkova NK; Vinogradov VN; Pavlovskaya AI; Chernyakhovskaya IY
Acta Virol; 1975 Jul; 19(4):293-8. PubMed ID: 241226
[TBL] [Abstract][Full Text] [Related]
26. A full UL13 open reading frame in Marek's disease virus (MDV) is dispensable for tumor formation and feather follicle tropism and cannot restore horizontal virus transmission of rRB-1B in vivo.
Blondeau C; Chbab N; Beaumont C; Courvoisier K; Osterrieder N; Vautherot JF; Denesvre C
Vet Res; 2007; 38(3):419-33. PubMed ID: 17506972
[TBL] [Abstract][Full Text] [Related]
27. Marek's disease virus infection in the eye: chronological study of the lesions, virus replication, and vaccine-induced protection.
Pandiri AK; Cortes AL; Lee LF; Gimeno IM
Avian Dis; 2008 Dec; 52(4):572-80. PubMed ID: 19166047
[TBL] [Abstract][Full Text] [Related]
28. Attenuation of Marek's disease virus by deletion of open reading frame RLORF4 but not RLORF5a.
Jarosinski KW; Osterrieder N; Nair VK; Schat KA
J Virol; 2005 Sep; 79(18):11647-59. PubMed ID: 16140742
[TBL] [Abstract][Full Text] [Related]
29. Deletion of Marek's disease virus large subunit of ribonucleotide reductase impairs virus growth in vitro and in vivo.
Sun A; Lee LF; Khan OA; Heidari M; Zhang H; Lupiani B; Reddy SM
Avian Dis; 2013 Jun; 57(2 Suppl):464-8. PubMed ID: 23901762
[TBL] [Abstract][Full Text] [Related]
30. [Immunological cross-reaction of serotype I Marek's disease virus 38kD phosphorylated protein with serotype II and III viruses].
Qin A; Cui Z; Duan Y
Wei Sheng Wu Xue Bao; 1994 Oct; 34(5):393-7. PubMed ID: 7871782
[TBL] [Abstract][Full Text] [Related]
31. Development of a cell line system susceptible to infection with vaccine strains of MDV.
Abujoub AA; Williams DL; Reilly JD
Acta Virol; 1999; 43(2-3):186-91. PubMed ID: 10696443
[TBL] [Abstract][Full Text] [Related]
32. Glycoproteins E and I of Marek's disease virus serotype 1 are essential for virus growth in cultured cells.
Schumacher D; Tischer BK; Reddy SM; Osterrieder N
J Virol; 2001 Dec; 75(23):11307-18. PubMed ID: 11689611
[TBL] [Abstract][Full Text] [Related]
33. Marek's disease virus encodes MicroRNAs that map to meq and the latency-associated transcript.
Burnside J; Bernberg E; Anderson A; Lu C; Meyers BC; Green PJ; Jain N; Isaacs G; Morgan RW
J Virol; 2006 Sep; 80(17):8778-86. PubMed ID: 16912324
[TBL] [Abstract][Full Text] [Related]
34. Protective efficacy of Marek's disease virus (MDV) CVI-988 CEF65 clone C against challenge infection with three very virulent MDV strains.
de Boer GF; Groenendal JE; Boerrigter HM; Kok GL; Pol JM
Avian Dis; 1986; 30(2):276-83. PubMed ID: 3015113
[TBL] [Abstract][Full Text] [Related]
35. Comparison of blood and feather pulp samples for the diagnosis of Marek's disease and for monitoring Marek's disease vaccination by real time-PCR.
Cortes AL; Montiel ER; Lemiere S; Gimeno IM
Avian Dis; 2011 Jun; 55(2):302-10. PubMed ID: 21793449
[TBL] [Abstract][Full Text] [Related]
36. Early posthatch protection against Marek's disease in chickens vaccinated in ovo with a CVI988 serotype 1 vaccine.
Zhang Y; Sharma JM
Avian Dis; 2001; 45(3):639-45. PubMed ID: 11569737
[TBL] [Abstract][Full Text] [Related]
37. Abundance of IFN-alpha and IFN-gamma mRNA in blood of resistant and susceptible chickens infected with Marek's disease virus (MDV) or vaccinated with turkey herpesvirus; and MDV inhibition of subsequent induction of IFN gene transcription.
Quéré P; Rivas C; Ester K; Novak R; Ragland WL
Arch Virol; 2005 Mar; 150(3):507-19. PubMed ID: 15592893
[TBL] [Abstract][Full Text] [Related]
38. Keratinocytes derived from chicken embryonic stem cells support Marek's disease virus infection: a highly differentiated cell model to study viral replication and morphogenesis.
Couteaudier M; Courvoisier K; Trapp-Fragnet L; Denesvre C; Vautherot JF
Virol J; 2016 Jan; 13():7. PubMed ID: 26742789
[TBL] [Abstract][Full Text] [Related]
39. Adaptation of Marek's disease virus to the Vero continuous cell line.
Jaikumar D; Read KM; Tannock GA
Vet Microbiol; 2001 Mar; 79(1):75-82. PubMed ID: 11230930
[TBL] [Abstract][Full Text] [Related]
40. A simple in vitro differentiation between turkey herpesvirus and Marek's disease virus.
Cho BR
Avian Dis; 1981; 25(4):839-46. PubMed ID: 6279072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
